COALITION FOR ACCESS TO NCD MEDICINES & PRODUCTS
About the Coalition
The global, multisectoral Coalition for Access to NCD Medicines & Products was launched in 2017. This Coalition of government agencies, private-sector entities, nongovernmental organizations, philanthropic foundations, and academic institutions is dedicated to increasing access to medicines and health products for noncommunicable diseases (NCDs) to reduce the impact of diseases such as diabetes, hypertension, and cardiovascular disease.
Stay Up to Date
The Coalition developed an NCD Forecasting Initiative for Essential Medicines and Products in partnership with the ministries of health in Kenya and Uganda and several local and global experts in forecasting. This program includes a forecasting tool, workshop materials, and user guides. It was initiated in Kenya and Uganda with plans to scale to other countries.
The Coalition co-hosted a side event at World Health Assembly 75 with PATH and the Leona M. and Harry B. Helmsley Charitable Trust. Moving toward equity: Innovative approaches to increase access to affordable NCD medicines and products.
Diabetes Supplies: Are they there when needed?
A global review of the availability and affordability of the 22 essential medicines and technologies for comprehensive diagnosis and treatment of diabetes, hypertension, and dyslipidemia in low-resource settings. A publication from the “No Empty Shelves: Diabetes Supplies, There When Needed” Project.
The Coalition’s blog series on COVID-19 and access to NCD medicines and products:
- NCD Medicines and Products – Not Just Resource Limited, but Resource Variable
- Improving Access to NCD Medicines and Products Will Help Build Future Pandemic Resilience
- Taking Critical Action on NCDs during the COVID-19 Response and Beyond
- Exacerbated Supply Chain Challenges During the COVID-19 Crisis & Creative Solutions that Bring Hope for People Living with NCDs
Check out these tools and resources from the World Health Organization and the NCD Alliance to learn more about COVID-19 & NCDs.